|
Financial Information Relating to Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Mar. 31, 2012
|
Mar. 31, 2011
|
Mar. 31, 2012
|
Mar. 31, 2011
|
|
| Segment Reporting Information [Line Items] | ||||
| External sales | $ 83,621 | $ 76,271 | $ 235,879 | $ 211,924 |
| Earnings before income taxes | 43,205 | 45,384 | 121,578 | 122,010 |
|
Biotechnology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 78,180 | 71,120 | 220,291 | 197,241 |
| Earnings before income taxes | 45,442 | 44,911 | 123,304 | 121,324 |
|
Hematology
|
||||
| Segment Reporting Information [Line Items] | ||||
| External sales | 5,441 | 5,151 | 15,588 | 14,683 |
| Earnings before income taxes | 2,037 | 1,947 | 5,636 | 5,296 |
|
Reportable Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | 47,479 | 46,858 | 128,940 | 126,620 |
|
Unallocated Amount to Segment
|
||||
| Segment Reporting Information [Line Items] | ||||
| Earnings before income taxes | $ (4,274) | $ (1,474) | $ (7,362) | $ (4,610) |